(2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid

C161H220ClF4N19O17 — CID 158020148

About (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid

(2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid (PubChem CID 158020148) has the molecular formula C161H220ClF4N19O17 and a molecular weight of 2805.09 g/mol. Its IUPAC name is (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid.

Molecular Properties

• Compound Name: (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid
• PubChem CID: 158020148
• Molecular Formula: C161H220ClF4N19O17
• Molecular Weight: 2805.09 g/mol
• Exact Mass: 2802.66
• IUPAC Name: (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid
• SMILES: CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1.CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1.CN(C(=O)NCc1ccc(OON)cc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1.O=C(CC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1)NCc1ccccc1.O=C(NCCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccccc1
• InChI: InChI=1S/C33H46FN5O5.C33H44FN3O3.C33H45N3O3.C31H43ClN4O3.C31H42F2N4O3/c1-37(33(42)36-19-23-10-12-29(13-11-23)43-44-35)28-14-16-38(17-15-28)20-26-21-39(22-30(26)25-8-5-9-27(34)18-25)31(32(40)41)24-6-3-2-4-7-24;34-29-13-7-12-27(19-29)30-23-37(32(33(39)40)26-10-5-2-6-11-26)22-28(30)21-36-16-14-24(15-17-36)18-31(38)35-20-25-8-3-1-4-9-25;37-32(28-14-8-3-9-15-28)34-19-16-25-17-20-35(21-18-25)22-29-23-36(24-30(29)26-10-4-1-5-11-26)31(33(38)39)27-12-6-2-7-13-27;1-4-36(31(39)33-18-23-10-12-26(32)13-11-23)27-14-16-34(17-15-27)19-25-20-35(29(22(2)3)30(37)38)21-28(25)24-8-6-5-7-9-24;1-4-37(31(40)34-17-22-10-11-27(32)28(33)16-22)25-12-14-35(15-13-25)18-24-19-36(29(21(2)3)30(38)39)20-26(24)23-8-6-5-7-9-23/h5,8-13,18,24,26,28,30-31H,2-4,6-7,14-17,19-22,35H2,1H3,(H,36,42)(H,40,41);1,3-4,7-9,12-13,19,24,26,28,30,32H,2,5-6,10-11,14-18,20-23H2,(H,35,38)(H,39,40);1,3-5,8-11,14-15,25,27,29-31H,2,6-7,12-13,16-24H2,(H,34,37)(H,38,39);5-13,22,25,27-29H,4,14-21H2,1-3H3,(H,33,39)(H,37,38);5-11,16,21,24-26,29H,4,12-15,17-20H2,1-3H3,(H,34,40)(H,38,39)/t26-,30+,31+;28-,30+,32+;29-,30+,31+;25-,28+,29+;24-,26+,29+/m00000/s1
• InChIKey: FFYPWDQYDMKLIC-OFYXXQFLSA-N
• XLogP: 24.87
• TPSA: 418.60 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 23
• Rotatable Bonds: 51
• Heavy Atoms: 202
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2805.09
LogP ≤ 5	24.87
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	23

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid?

The IUPAC name of (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid (CID 158020148) is (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid.

What is the SMILES notation for (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid?

The canonical SMILES for (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid is CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1.CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1.CN(C(=O)NCc1ccc(OON)cc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1.O=C(CC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1)NCc1ccccc1.O=C(NCCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccccc1.

What is the InChIKey of (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid?

The InChIKey is FFYPWDQYDMKLIC-OFYXXQFLSA-N. The full InChI is InChI=1S/C33H46FN5O5.C33H44FN3O3.C33H45N3O3.C31H43ClN4O3.C31H42F2N4O3/c1-37(33(42)36-19-23-10-12-29(13-11-23)43-44-35)28-14-16-38(17-15-28)20-26-21-39(22-30(26)25-8-5-9-27(34)18-25)31(32(40)41)24-6-3-2-4-7-24;34-29-13-7-12-27(19-29)30-23-37(32(33(39)40)26-10-5-2-6-11-26)22-28(30)21-36-16-14-24(15-17-36)18-31(38)35-20-25-8-3-1-4-9-25;37-32(28-14-8-3-9-15-28)34-19-16-25-17-20-35(21-18-25)22-29-23-36(24-30(29)26-10-4-1-5-11-26)31(33(38)39)27-12-6-2-7-13-27;1-4-36(31(39)33-18-23-10-12-26(32)13-11-23)27-14-16-34(17-15-27)19-25-20-35(29(22(2)3)30(37)38)21-28(25)24-8-6-5-7-9-24;1-4-37(31(40)34-17-22-10-11-27(32)28(33)16-22)25-12-14-35(15-13-25)18-24-19-36(29(21(2)3)30(38)39)20-26(24)23-8-6-5-7-9-23/h5,8-13,18,24,26,28,30-31H,2-4,6-7,14-17,19-22,35H2,1H3,(H,36,42)(H,40,41);1,3-4,7-9,12-13,19,24,26,28,30,32H,2,5-6,10-11,14-18,20-23H2,(H,35,38)(H,39,40);1,3-5,8-11,14-15,25,27,29-31H,2,6-7,12-13,16-24H2,(H,34,37)(H,38,39);5-13,22,25,27-29H,4,14-21H2,1-3H3,(H,33,39)(H,37,38);5-11,16,21,24-26,29H,4,12-15,17-20H2,1-3H3,(H,34,40)(H,38,39)/t26-,30+,31+;28-,30+,32+;29-,30+,31+;25-,28+,29+;24-,26+,29+/m00000/s1.

What are the key properties of (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid?

(2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid has a molecular weight of 2805.09 g/mol, XLogP of 24.87, 51 rotatable bonds, 11 hydrogen bond donors, and 23 hydrogen bond acceptors.

Where does this data come from?

All data for (2R)-2-[(3S,4S)-3-[[4-[(4-aminoperoxyphenyl)methylcarbamoyl-methylamino]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-(2-benzamidoethyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[2-(benzylamino)-2-oxoethyl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)pyrrolidin-1-yl]-2-cyclohexylacetic acid;(2R)-2-[(3S,4S)-3-[[4-[(4-chlorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid;(2R)-2-[(3S,4S)-3-[[4-[(3,4-difluorophenyl)methylcarbamoyl-ethylamino]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-3-methylbutanoic acid is sourced from PubChem (CID 158020148), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).